• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉直径增加可预测肝硬化患者门静脉血栓形成。

Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis.

作者信息

Dong Gang, Huang Xiao-Quan, Zhu Yu-Li, Ding Hong, Li Feng, Chen Shi-Yao

机构信息

Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.

Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Ann Transl Med. 2021 Feb;9(4):289. doi: 10.21037/atm-20-4912.

DOI:10.21037/atm-20-4912
PMID:33708916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7944309/
Abstract

BACKGROUND

Cirrhotic patients with portal vein thrombosis (PVT) may have a high risk of hepatic decompensation and increased mortality. This study aimed to investigate if increased portal vein diameter is associated with PVT development.

METHODS

A total of 174 cirrhotic patients were enrolled between February 1 and August 31, 2017. All participants were divided into PVT (n=62) and non-PVT (n=112) groups based on the thrombus that was detected by ultrasonography and confirmed by computed tomography angiography (CTA).

RESULTS

The study participants, aged 54.7±10.5 years (PVT) and 55.8±11.6 years (non-PVT), were included in this analysis. The Child-Pugh score of PVT or non-PVT was 6.6±1.3 and 5.8±0.9, respectively. Hepatitis B virus (HBV) is the primary etiological agent of cirrhosis. Logistic regression, receiver operating characteristic (ROC), and nomograph analysis designated portal diameter as the strongest independent risk factor for predicting PVT development [odds ratio (OR): 3.96, area under the ROC curve (AUC): 0.88; P<0.01], and the cutoff with predictive value for PVT development was >12.5 mm. No differences were observed in the overall survival (OS) in cirrhosis with or without PVT or stratifying on portal diameter based on the cutoff value.

CONCLUSIONS

Increased portal diameter is associated with an increased risk of PVT development. Patients with cirrhosis and increased portal diameter are a high-risk subgroup that may need thromboprophylaxis.

摘要

背景

门静脉血栓形成(PVT)的肝硬化患者可能有肝失代偿风险增加和死亡率升高的情况。本研究旨在调查门静脉直径增加是否与PVT的发生有关。

方法

2017年2月1日至8月31日共纳入174例肝硬化患者。所有参与者根据超声检查发现并经计算机断层血管造影(CTA)证实的血栓分为PVT组(n = 62)和非PVT组(n = 112)。

结果

本分析纳入了年龄为54.7±10.5岁(PVT组)和55.8±11.6岁(非PVT组)的研究参与者。PVT组和非PVT组的Child-Pugh评分分别为6.6±1.3和5.8±0.9。乙型肝炎病毒(HBV)是肝硬化的主要病因。逻辑回归、受试者工作特征(ROC)和列线图分析将门静脉直径确定为预测PVT发生的最强独立危险因素[比值比(OR):3.96,ROC曲线下面积(AUC):0.88;P<0.01],预测PVT发生的临界值为>12.5 mm。无论有无PVT的肝硬化患者,或根据临界值按门静脉直径分层,总体生存率(OS)均未观察到差异。

结论

门静脉直径增加与PVT发生风险增加有关。肝硬化且门静脉直径增加的患者是一个可能需要进行血栓预防的高危亚组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/7944309/6f8ee28dd518/atm-09-04-289-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/7944309/2051cea2e1e6/atm-09-04-289-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/7944309/6f8ee28dd518/atm-09-04-289-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/7944309/2051cea2e1e6/atm-09-04-289-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/7944309/6f8ee28dd518/atm-09-04-289-f3.jpg

相似文献

1
Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis.门静脉直径增加可预测肝硬化患者门静脉血栓形成。
Ann Transl Med. 2021 Feb;9(4):289. doi: 10.21037/atm-20-4912.
2
Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers.基于炎症生物标志物的肝硬化相关性非恶性门静脉血栓形成预测模型
World J Gastrointest Oncol. 2024 Apr 15;16(4):1213-1226. doi: 10.4251/wjgo.v16.i4.1213.
3
Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study.门静脉速度降低可预测门静脉血栓形成的发生:一项配对病例对照研究。
Liver Int. 2018 Jan;38(1):94-101. doi: 10.1111/liv.13500. Epub 2017 Sep 9.
4
A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors.一项关于肝硬化患者门静脉血栓形成的单中心医院研究——临床特征与危险因素。
Indian J Med Res. 2014 Feb;139(2):260-6.
5
[Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].肝硬化合并门静脉血栓形成的临床特征及相关危险因素
Zhonghua Gan Zang Bing Za Zhi. 2016 Jul 20;24(7):513-517. doi: 10.3760/cma.j.issn.1007-3418.2016.07.006.
6
A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis.基于全身炎症标志物的实用列线图预测肝硬化患者门静脉血栓形成。
Ann Med. 2022 Dec;54(1):302-309. doi: 10.1080/07853890.2022.2028893.
7
Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients.肝硬化患者门静脉血栓形成的发病率及临床表现
Hepatobiliary Pancreat Dis Int. 2016 Oct;15(5):499-503. doi: 10.1016/s1499-3872(16)60092-9.
8
Nomogram for Predicting Portal Vein Thrombosis in Cirrhotic Patients: A Retrospective Cohort Study.预测肝硬化患者门静脉血栓形成的列线图:一项回顾性队列研究
J Pers Med. 2023 Jan 1;13(1):103. doi: 10.3390/jpm13010103.
9
Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.肝硬化门静脉血栓形成的相关危险因素:一项病例对照研究。
Ter Arkh. 2019 Mar 18;91(2):73-81. doi: 10.26442/00403660.2019.02.000153.
10
De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.肝硬化患者的新发门静脉血栓形成:危险因素及与终末期肝病模型评分系统的相关性
Eur J Gastroenterol Hepatol. 2015 May;27(5):585-92. doi: 10.1097/MEG.0000000000000325.

引用本文的文献

1
Three main portal veins: A very rare case of portal vein anomaly.三条主要门静脉:门静脉异常的一个极其罕见的病例。
J Clin Imaging Sci. 2024 Oct 28;14:41. doi: 10.25259/JCIS_107_2024. eCollection 2024.
2
A comprehensive evaluation system for ultrasound-guided infusion of human umbilical cord-derived MSCs in liver cirrhosis patients.肝硬化患者超声引导下输注人脐带间充质干细胞的综合评估系统
Stem Cells Transl Med. 2025 Jan 17;14(1). doi: 10.1093/stcltm/szae081.
3
The Molecular Mechanisms of Portal Vein Thrombosis in Hepatocellular Carcinoma.

本文引用的文献

1
Simvastatin Mitigates Apoptosis and Transforming Growth Factor-Beta Upregulation in Stretch-Induced Endothelial Cells.辛伐他汀减轻拉伸诱导的内皮细胞凋亡和转化生长因子-β上调。
Oxid Med Cell Longev. 2019 Dec 17;2019:6026051. doi: 10.1155/2019/6026051. eCollection 2019.
2
The risk factors of portal vein thrombosis in patients with liver cirrhosis.肝硬化患者门静脉血栓形成的危险因素
Exp Ther Med. 2019 Apr;17(4):3189-3194. doi: 10.3892/etm.2019.7300. Epub 2019 Feb 22.
3
Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.
肝细胞癌门静脉血栓形成的分子机制
Cancers (Basel). 2024 Sep 24;16(19):3247. doi: 10.3390/cancers16193247.
4
Portal Vein Thrombosis in COVID-19: An Underdiagnosed Disease?新型冠状病毒肺炎中的门静脉血栓形成:一种诊断不足的疾病?
J Clin Med. 2024 Sep 21;13(18):5599. doi: 10.3390/jcm13185599.
5
Diagnostic Prediction of portal vein thrombosis in chronic cirrhosis patients using data-driven precision medicine model.基于数据驱动的精准医学模型对慢性肝硬化患者门静脉血栓形成的诊断预测。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad478.
6
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis.血管性肝脏疾病的分子机制:聚焦于血栓形成。
Int J Mol Sci. 2023 Aug 13;24(16):12754. doi: 10.3390/ijms241612754.
7
Nomogram-based prediction of portal vein system thrombosis formation after splenectomy in patients with hepatolenticular degeneration.基于列线图预测肝豆状核变性患者脾切除术后门静脉系统血栓形成
Front Med (Lausanne). 2023 Feb 23;10:1103223. doi: 10.3389/fmed.2023.1103223. eCollection 2023.
8
Nomogram for Predicting Portal Vein Thrombosis in Cirrhotic Patients: A Retrospective Cohort Study.预测肝硬化患者门静脉血栓形成的列线图:一项回顾性队列研究
J Pers Med. 2023 Jan 1;13(1):103. doi: 10.3390/jpm13010103.
9
A novel potential mechanism for the development of portal vein thrombosis in cirrhosis based on portal hemodynamics.基于门静脉血流动力学的肝硬化门静脉血栓形成的一种新型潜在机制。
Insights Imaging. 2022 Dec 13;13(1):192. doi: 10.1186/s13244-022-01330-4.
10
Nomogram for Predicting Postoperative Portal Venous Systemic Thrombosis in Patients with Cirrhosis Undergoing Splenectomy and Esophagogastric Devascularization.肝硬化患者脾切除+贲门周围血管离断术后术后门静脉系统血栓形成的预测列线图
Can J Gastroenterol Hepatol. 2022 Nov 4;2022:8084431. doi: 10.1155/2022/8084431. eCollection 2022.
肝硬化与非肝硬化患者门静脉血栓形成的诊断、发展和治疗。
Gastroenterology. 2019 May;156(6):1582-1599.e1. doi: 10.1053/j.gastro.2019.01.265. Epub 2019 Feb 13.
4
Serum ADAMTS-13 Levels as an Indicator of Portal Vein Thrombosis.血清ADAMTS-13水平作为门静脉血栓形成的指标
Gastroenterol Res Pract. 2018 Apr 18;2018:3287491. doi: 10.1155/2018/3287491. eCollection 2018.
5
Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study.门静脉速度降低可预测门静脉血栓形成的发生:一项配对病例对照研究。
Liver Int. 2018 Jan;38(1):94-101. doi: 10.1111/liv.13500. Epub 2017 Sep 9.
6
Endotoxemia as a trigger of thrombosis in cirrhosis.内毒素血症作为肝硬化中血栓形成的触发因素。
Haematologica. 2016 Apr;101(4):e162-3. doi: 10.3324/haematol.2015.139972.
7
Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients.移植前门静脉血栓形成是肝移植受者因肝动脉血栓形成导致移植物丢失的独立危险因素。
HPB (Oxford). 2016 Mar;18(3):279-86. doi: 10.1016/j.hpb.2015.10.008. Epub 2015 Dec 10.
8
Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis.肝硬化患者门静脉血栓形成、死亡率及肝失代偿:一项荟萃分析。
World J Hepatol. 2015 Nov 28;7(27):2774-80. doi: 10.4254/wjh.v7.i27.2774.
9
Portal vein thrombosis in liver cirrhosis.肝硬化中的门静脉血栓形成
World J Hepatol. 2014 Feb 27;6(2):64-71. doi: 10.4254/wjh.v6.i2.64.
10
Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis.初发性门静脉血栓形成和肝硬化患者的血小板指数
Rev Med Chir Soc Med Nat Iasi. 2013 Jul-Sep;117(3):641-7.